Perfuze Millipede88 restores blood flow in 89% of patients in pivotal stroke thrombectomy study
Final MARRS pivotal-trial results show Perfuze’s FDA-cleared Millipede88 aspiration catheter achieved 89% successful reperfusion without rescue therapy and a 75% first-pass effect in M1 middle cerebral artery occlusions.